Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Ennis
EBF
$559M
| $40.3M | 0.03% |
1,859,482
+141,182
| +8% | +$2.87M |
|
627
HF Sinclair
DINO
$16.3B
| $40.2M | 0.03% |
793,381
+296,399
| +60% | +$15.7M |
|
628
Forrester Research
FORR
$224M
| $40.2M | 0.03% |
964,406
+34,388
| +4% | +$1.28M |
|
629
Lamb Weston
LW
$7.39B
| $40.1M | 0.03% |
466,200
-41,900
| -8% | -$3.37M |
|
630
Winmark
WINA
$1.26B
| $40M | 0.03% |
201,797
+13,797
| +7% | +$2.49M |
|
|
HSII
631
DELISTED
Heidrick & Struggles
HSII
| $40M | 0.03% |
1,230,600
+3,898
| +0.3% | +$115K |
|
|
CVGW
632
DELISTED
Calavo Growers
CVGW
| $40M | 0.03% |
441,420
+122,500
| +38% | +$10.9M |
|
|
TMHC
633
DELISTED
Taylor Morrison
TMHC
| $40M | 0.03% |
1,828,192
+1,438,000
| +369% | +$34.6M |
|
|
DRE
634
DELISTED
Duke Realty Corp.
DRE
| $39.8M | 0.03% |
1,148,300
+247,500
| +27% | +$8.54M |
|
635
PBF Energy
PBF
$8.81B
| $39.8M | 0.03% |
1,268,400
+524,900
| +71% | +$16.1M |
|
|
HDS
636
DELISTED
HD Supply Holdings, Inc.
HDS
| $39.8M | 0.03% |
989,003
+928,703
| +1,540% | +$36.9M |
|
637
Takeda Pharmaceutical
TAK
$55.5B
| $39.6M | 0.03% |
2,008,189
+303,789
| +18% | +$5.81M |
|
638
Allegion
ALLE
$14.2B
| $39.5M | 0.03% |
317,300
+243,500
| +330% | +$28.1M |
|
639
Shutterstock
SSTK
$217M
| $39.4M | 0.03% |
917,700
+43,500
| +5% | +$1.75M |
|
640
World Kinect Corp
WKC
$1.9B
| $39.2M | 0.03% |
903,173
+54,300
| +6% | +$2.27M |
|
641
Suzano
SUZ
$9.84B
| $39.2M | 0.03% |
3,979,838
-317,885
| -7% | -$2.82M |
|
642
Stepan Co
SCL
$1.48B
| $39M | 0.03% |
381,200
+13,200
| +4% | +$1.29M |
|
|
MGP
643
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $38.9M | 0.03% |
1,257,500
+377,400
| +43% | +$11.6M |
|
644
Sea Limited
SE
$75.5B
| $38.8M | 0.03% |
964,397
-18,703
| -2% | -$630K |
|
|
SEE
645
DELISTED
Sealed Air
SEE
| $38.7M | 0.03% |
971,408
-525,801
| -35% | -$20.8M |
|
|
MIME
646
DELISTED
Mimecast Limited
MIME
| $38.7M | 0.03% |
891,385
-697,015
| -44% | -$29M |
|
|
CLGX
647
DELISTED
Corelogic, Inc.
CLGX
| $38.7M | 0.03% |
884,310
-102,890
| -10% | -$4.38M |
|
648
Rollins
ROL
$17.4B
| $38.5M | 0.03% |
+1,740,320
| New | +$41.2M |
|
649
TransUnion
TRU
$15.5B
| $38.5M | 0.03% |
+449,300
| New | +$37.4M |
|
|
SCS
650
DELISTED
Steelcase
SCS
| $38.5M | 0.03% |
1,879,900
+483,800
| +35% | +$8.97M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.